Atlas Trials

Taiho Pharmaceutical Co., Ltd.

43 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Taiho Pharmaceutical Co., Ltd.

RecordFirmDate
Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer (NCT07710885)Taiho Pharmaceutical Co., Ltd.2026-06-24
A Study of TAS3731 in Healthy Adults (NCT05691660)Taiho Pharmaceutical Co., Ltd.2023-01-17
A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects (NCT05621447)Taiho Pharmaceutical Co., Ltd.2022-09-07
A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria (NCT05335499)Taiho Pharmaceutical Co., Ltd.2022-06-28
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) (NCT05245968)Taiho Pharmaceutical Co., Ltd.2021-12-01
AB122 Platform Study (NCT04999761)Taiho Pharmaceutical Co., Ltd.2021-06-01
Mass Balance Study of [14C] TAS-205 in Healthy Volunteers (NCT04825431)Taiho Pharmaceutical Co., Ltd.2021-03-22
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities (NCT04683250)Taiho Pharmaceutical Co., Ltd.2020-12-16
A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy(REACH-DMD) (NCT04587908)Taiho Pharmaceutical Co., Ltd.2020-11-01
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome (NCT04608110)Taiho Pharmaceutical Co., Ltd.2020-10-30
Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. (NCT03605251)Taiho Pharmaceutical Co., Ltd.2018-08-30
Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. (NCT03175029)Taiho Pharmaceutical Co., Ltd.2017-09-09

Track Taiho Pharmaceutical Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.